Management of hyponatremia: causes, clinical aspects, differential diagnosis and treatment

References

• Liamis G, Rodenburg EM, Hofman A, et al. Electrolyte disorders in community subjects: prevalence and risk factors. Am J Med. 2013;126:256–263.
   PubMed Web of Science ®Google Scholar
• Miller AJ, Theou O, McMillan M, et al. Dysnatremia in relation to frailty and age in community-dwelling adults in the national health and nutrition examination survey. J Gerontol A Biol Sci Med Sci. 2017;72:376–381.
   PubMed Web of Science ®Google Scholar
• Waikar SS, Mount DB, Curhan GC. Mortality after hospitalization with mild, moderate, and severe hyponatremia. Am J Med. 2009;122:857–865.
   PubMed Web of Science ®Google Scholar
• Hoorn EJ, Lindemans J, Zietse R. Development of severe hyponatraemia in hospitalized patients: treatment-related risk factors and inadequate management. Nephrol Dial Transplant. 2006;21:70–76.
   PubMed Web of Science ®Google Scholar
• Hao J, Li Y, Zhang X, et al. The prevalence and mortality of hyponatremia is seriously underestimated in Chinese general medical patients: an observational retrospective study. BMC Nephrol. 2017;18:328.
   PubMed Web of Science ®Google Scholar
• Tormey WP, Carney M, Cuesta M, et al. Reference change values for sodium are ignored by the American and European treatment guidelines for hyponatremia. Clin Chem. 2015;61:1430–1432.
   PubMed Web of Science ®Google Scholar
• Gennari FJ. Hypo-hypernatraemia: disorders of water balance. In: Davison AM, Cameron JS, Grünfeld J-P, et al., editors. Oxford textbook of clinical nephrology. Vol. 1. 2nd ed. Oxford, England: Oxford University Press; 1998. p. 175–200.
   Google Scholar
• Adrogué HJ, Madias EN. Hyponatremia. N Eng J Med. 2000;342:1581–1589.
   PubMed Web of Science ®Google Scholar
• Feldman BJ, Rosenthal SM, Vargas GA, et al. Nephrogenic syndrome of inappropriate antidiuresis. N Engl J Med. 2005;352:1884–1890.
   PubMed Web of Science ®Google Scholar
• Robinson AG, Verbalis JG. The syndrome of inappropriate antidiuretic hormone secretion. In: Larsen PR, et al., editor. Williams textbook of endocrinology. 10th ed. Philadelphia:WB Saunders; 2002. p.300–313.
   Google Scholar
• Diederich S, Franzen NF, Bähr V, et al. Severe hyponatremia due to hypopituitarism with adrenal insufficiency: report on 28 cases. Eur J Endocrinol. 2003;148:609–617.
   PubMed Web of Science ®Google Scholar
• Chanson P. Severe hyponatremia as a frequent revealing sign of hypopituitarism after 60 years of age. Eur J Endocrinol. 2003;149:177–178.
   PubMed Web of Science ®Google Scholar
• Raff H. Glucocorticoid inhibition of neurohypophysial vasopressin secretion. Am J Physiol. 1987;252:R635–644.
   PubMed Web of Science ®Google Scholar
• Saito T, Ishikawa SE, Ando F, et al. Vasopressin-dependent upregulation of aquaporin-2 gene expression in glucocorticoid-defidient rats. Am J Physiol Renal Physiol. 2000;279:F502–F508.
   PubMed Web of Science ®Google Scholar
• Larsen PR, Davies TF. Hypothyroidism. In: Larsen PR, et al., editor. Williams textbook of endocrinology. 10th ed. Philadelphia:WB Saunders; 2002. p.423–455.
   Google Scholar
• Warner MH, Holding S, Kilpatrick ES. The effect of newly diagnosed hypothyroidism on serum sodium concentrations: a retrospective study. Clin Endocrinol. 2006;64:598–599.
   PubMed Web of Science ®Google Scholar
• Arieff AI, Llach F, Massry SG. Neurological manifestations and morbidity of hyponatremia: correlation with brain water and electrolytes. Medicine (Baltimore). 1976;55:121–129.
   PubMed Web of Science ®Google Scholar
• Fraser CL, Arieff AI. Epidemiology, pathophysiology, and management of hyponatremic encephalopathy. Am J Med. 1997;102:67–77.
   PubMed Web of Science ®Google Scholar
• Renneboog B, Musch W, Vandemergel X, et al. Mild chronic hyponatremia is associated with falls, unsteadiness and attention deficits. Am J Med. 2006;119:71.e1–8.
   PubMedGoogle Scholar
• Kinsella S, Moran S, Sullivan MO, et al. Hyponatremia independent of osteoporosis is associated with fracture occurrence. Clin J Am Soc Nephrol. 2010;5:275–280.
   PubMed Web of Science ®Google Scholar
• Hoorn EJ, Liamis G, Zietse R, et al. Hyponatremia and bone: an emerging relationship. Nat Rev Endocrinol. 2011;25:33–39.
   Google Scholar
• Verbalis JG, Barsony J, Sugimura Y, et al. Hyponatremia-induced osteoporosis. J Bone Miner Res. 2010;25:554–563.
   PubMed Web of Science ®Google Scholar
• Corona G, Norello D, Parenti G, et al. Hyponatremia, falls and bone fractures: a systematic review and meta-analysis. Clin Endocrinol (Oxf). 2018. Published online 19 June 2018. DOI:10.1111/cen.13790
   Web of Science ®Google Scholar
• de Leon J. Polydipsia – a study in a long-term psychiatric unit. Eur Arch Psychiatry Clin Neurosci. 2003;253:37–39.
   PubMed Web of Science ®Google Scholar
• Torres IJ, Keedy S, Marlow-O’Connor M, et al. Neuropsychological impairment in patients with schizophrenia and evidence of hyponatremia and polydipsia. Neuropsychology. 2009;23:307–314.
   PubMed Web of Science ®Google Scholar
• Shavit L, Mikeladze I, Torem C, et al. Mild hyponatremia is associated with functional and cognitive decline in chronic hemodialysis patients. Clin Nephrol. 2014;82:313–319.
   PubMed Web of Science ®Google Scholar
• Verbalis JG, Ellison H, Hobart M, et al. Tolvaptan and neurocognitive function in mild to moderate chronic hyponatremia: a randomized trial (INSIGHT). Am J Kidney Dis. 2016;67:893–901.
   PubMed Web of Science ®Google Scholar
• Chung MC, Yu TM, Shu KH, et al. Hyponatremia and increased risk of dementia: a population-based retrospective cohort study. PLoS One. 2017;12:e0178977.
   PubMed Web of Science ®Google Scholar
• Josiassen RC, Filmyer DM, Geboy AG, et al. Psychomotor deficits associated with hyponatremia: a retrospective analysis. Clin Neuropsychol. 2012;26:74–87.
   PubMed Web of Science ®Google Scholar
• Geboy AG, Filmyer DM, Josiassen RC. Motor deficits associated with mild, chronic hyponatremia: a factor analytic study. J Mot Behav. 2012;44:255–259.
   PubMed Web of Science ®Google Scholar
• Barsony J, Manigrasso MB, Xu Q, et al. Chronic hyponatremia exacerbates multiple manifestations of senescence in male rats. Age (Dordr). 2013;35:271–288.
   PubMedGoogle Scholar
• Wald R, Jaber BL, Price LL. Impact of hospital-associated hyponatremia on selected outcomes. Arch Intern Med. 2010;170:294–302.
   PubMed Web of Science ®Google Scholar
• Corona G, Giuliani C, Parenti G, et al. Moderate hyponatremia is associated with increased risk of mortality: evidence from a meta-analysis. PLoS One. 2013;8:e80451.
   PubMed Web of Science ®Google Scholar
• Corona G, Giuliani C, Verbalis JG, et al. Hyponatremia improvement is associated with a reduced risk of mortality: evidence from a meta-analysis. PLoS One. 2015;10:e0124105.
   PubMed Web of Science ®Google Scholar
• Zilberberg MD, Exuzides A, Spalding J, et al. Epidemiology, clinical and economic outcomes of admission hyponatremia among hospitalized patients. Curr Med Res Opin. 2008;24:1601–1608.
   PubMed Web of Science ®Google Scholar
• Adrogué HJ. Consequences of inadequate management of hyponatremia. Am J Nephrol. 2005;25:240–249.
   PubMed Web of Science ®Google Scholar
• Deitelzweig S, Amin A, Christian R, et al. Hyponatremia-associated healthcare burden among US patients hospitalized for cirrhosis. Adv Ther. 2013;30:71–80.
   PubMed Web of Science ®Google Scholar
• Amin A, Deitelzweig S, Christian R, et al. Healthcare resource burden associated with hyponatremia among patients hospitalized for heart failure in the US. J Med Econ. 2013;16:415–420.
   PubMedGoogle Scholar
• Corona G, Giuliani C, Parenti G, et al. The economic burden of hyponatremia: systematic review and meta-analysis. Am J Med. 2016;129823–835.e4.
   PubMed Web of Science ®Google Scholar
• Verbalis JG, Goldsmith SR, Greenberg A, et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med. 2013;126(Suppl1):S1–S42.
   PubMedGoogle Scholar
• Spasovski G, Vanholder R, Allolio B, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol. 2014;25:G1–G47.
   Google Scholar
• Avcil M, Kapci M, Dagli B, et al. Comparison of ultrasound-based methods of jugular vein and inferior vena cava for estimating central venous pressure. Int J Clin Exp Med. 2015;8:10586–10594.
   PubMed Web of Science ®Google Scholar
• Rizkallah J, Jack M, Saeed M, et al. Non-invasive bedside assessment of central venous pressure: scanning into the future. PLoS One. 2014;9:e109215.
   PubMed Web of Science ®Google Scholar
• Corona G, Simonetti L, Giuliani C, et al. A case of osmotic demyelination syndrome occurred after the correction of severe hyponatraemia in hyperemesis gravidarum. BMC Endocr Disord. 2014;14:34.
   PubMed Web of Science ®Google Scholar
• Schwartz WB, Bennett W, Curelop S, et al. A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am J Med. 1957;23:529–542.
   PubMed Web of Science ®Google Scholar
• Furst H, Hallows KR, Post J, et al. The urine/plasma electrolyte ratio: a predictive guide to water restriction. Am J Med Sci. 2000;319:240–244.
   PubMed Web of Science ®Google Scholar
• Peri A, Pirozzi N, Parenti G, et al. Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). J Endocrinol Invest. 2010;33:671–682.
   PubMed Web of Science ®Google Scholar
• deGoma EM, Vagelos RH, Fowler MB, et al. Emerging therapies for the management of decompensated heart failure: from bench to bedside. J Am Coll Cardiol. 2006;48:2397–2409.
   PubMed Web of Science ®Google Scholar
• Ohnishi A, Orita Y, Okahara R, et al. Potent aquaretic agent. A novel nonpeptide selective vasopressin 2 antagonist (OPC-31260) in men. J Clin Invest. 1993;92:2653–2659.
   PubMed Web of Science ®Google Scholar
• Zeltser D, Rosansky S, van Rensburg H, et al. Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia. Am J Nephrol. 2007;27:447–457.
   PubMed Web of Science ®Google Scholar
• Peri A. Clinical review: the use of vaptans in clinical endocrinology. J Clin Endocrinol Metab. 2013;98:1321–1332.
   PubMed Web of Science ®Google Scholar
• Bhandari S, Peri A, Cranston I, et al. A systematic review of known interventions for the treatment of chronic nonhypovolaemic hypotonic hyponatraemia and a meta-analysis of the vaptans. Clin Endocrinol (Oxf). 2017;86:761–771.
   PubMed Web of Science ®Google Scholar
• Schrier RW, Gross P, Gheorghiade M, et al. SALT investigators. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med. 2006;355:2099–2112.
   PubMed Web of Science ®Google Scholar
• Berl T, Quittnat-Pelletier F, Verbalis JG, et al. SALTWATER investigators. Oral tolvaptan is safe and effective in chronic hyponatremia. J Am Soc Nephrol. 2010;21:705–712.
   PubMed Web of Science ®Google Scholar
• Torres VE, Chapman AB, Devuyst O, et al. TEMPO 3:4 trial investigators. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med. 2012;367:2407–2418.
   PubMed Web of Science ®Google Scholar
• Aylwin S, Burst V, Peri A, et al. ‘Dos and don’ts’ in the management of hyponatremia. Curr Med Res Opin. 2015;31:1755–1761.
   PubMed Web of Science ®Google Scholar
• Castello LM, Baldrighi M, Panizza A, et al. Efficacy and safety of two different tolvaptan doses in the treatment of hyponatremia in the emergency department. Intern Emerg Med. 2017;12:993–1001.
   PubMed Web of Science ®Google Scholar
• Shoaf SE, Bricmont P, Mallikaarjun S. Effects of CYP3A4 inhibition and induction on the pharmacokinetics and pharmacodynamics of tolvaptan, a non-peptide AVP antagonist in healthy subjects. Br J Clin Pharmacol. 2012;73:579–587.
   PubMed Web of Science ®Google Scholar
• Shoaf SE, Mallikaarjun S. Bricmont P effect of grapefruit juice on the pharmacokinetics of tolvaptan, a non-peptide arginine vasopressin antagonist, in healthy subjects. Eur J Clin Pharmacol. 2012;68:207–211.
   PubMed Web of Science ®Google Scholar
• Shoaf SE, Ohzone Y, Ninomiya S, et al. In vitro P-glycoprotein interactions and steady-state pharmacokinetic interactions between tolvaptan and digoxin in healthy subjects. J Clin Pharmacol. 2011;51:761–769.
   PubMed Web of Science ®Google Scholar
• Greenberg A, Verbalis JG, Amin AN, et al. Current treatment practice and outcomes. Report of the hyponatremia registry. Kidney Int. 2015;88:167–177.
   PubMed Web of Science ®Google Scholar